CARGO Therapeutics, Inc. Common Stock (CRGX)
USD 12.81
(-13.21%)
USD 12.81
(-13.21%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -81.16 Million | -29.07 Million | -4.94 Million |
| Net Income | -98.14 Million | -40.95 Million | -5.85 Million |
| Depreciation & Amortization | 3.69 Million | 1.44 Million | 147 Thousand |
| Deferred income taxes | -4.13 Million | 1.21 Million | - |
| Stock-based compensation | 3.32 Million | 297 Thousand | 507 Thousand |
| Change in working capital | 2.2 Million | 2.96 Million | 254 Thousand |
| Other non-cash items | 11.89 Million | 5.95 Million | 469 Thousand |
| Investing Cash Flow | -8.99 Million | -3.28 Million | -442 Thousand |
| Investments in PPE | -8.99 Million | -3.28 Million | -442 Thousand |
| Acquisitions | - | - | - |
| Investment purchases | - | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -715 Thousand | -558 Thousand | - |
| Financing Cash Flow | 494.58 Million | 34.18 Million | 5.41 Million |
| Debt repayment | -3.49 Million | -28.45 Million | - |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 296.6 Million | 5.73 Million | 5.41 Million |
| Other Financing Activities | 197.97 Million | - | - |
| Accounts receivables | - | - | - |
| Accounts payables | 757 Thousand | 2.81 Million | 332 Thousand |
| Inventory | - | - | - |
| Other working capital | 1.45 Million | 148 Thousand | -78 Thousand |
| Cash at beginning of period | 1.87 Million | 41 Thousand | 11 Thousand |
| Cash at end of period | 406.29 Million | 1.87 Million | 41 Thousand |
| Capital Expenditure | -8.99 Million | -3.28 Million | -442 Thousand |
| Effect of forex changes on cash | - | - | - |
| Net cash flow / Change in cash | 404.42 Million | 1.83 Million | 30 Thousand |
| Free Cash Flow | -90.15 Million | -32.35 Million | -5.38 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -44.34 Million | -35.81 Million | -98.14 Million | -32.07 Million | -35.47 Million | -17.85 Million |
| Depreciation & Amortization | 2.06 Million | 1.85 Million | 3.69 Million | 1.1 Million | 1.04 Million | 859 Thousand |
| Deferred income taxes | - | - | -4.13 Million | - | - | - |
| Stock-based compensation | 4.3 Million | 3.9 Million | 3.32 Million | 1.62 Million | 1.08 Million | 592 Thousand |
| Change in working capital | 4.19 Million | 2.08 Million | 2.2 Million | -346 Thousand | 1.71 Million | 864 Thousand |
| Other non-cash items | 7.48 Million | 150 Thousand | 11.89 Million | 720 Thousand | 8.41 Million | 635 Thousand |
| Investing Cash Flow | 3.79 Million | -293.95 Million | -8.99 Million | -2.97 Million | -3.9 Million | -1.49 Million |
| Investments in PPE | -1.46 Million | -1.61 Million | -8.99 Million | -2.97 Million | -3.9 Million | -1.49 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -68.04 Million | -292.33 Million | - | - | - | - |
| Sales/Maturities of investments | 73.79 Million | - | - | - | - | - |
| Other Investing Activities | -500 Thousand | -330 Thousand | -715 Thousand | -357 Thousand | - | - |
| Financing Cash Flow | 103.34 Million | -104 Thousand | 494.58 Million | 377.91 Million | 45.09 Million | 2000.00 |
| Debt repayment | - | - | -3.49 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 103.21 Million | 26 Thousand | 296.6 Million | 382.64 Million | - | - |
| Other Financing Activities | 130 Thousand | -130 Thousand | 197.97 Million | 377.91 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -351 Thousand | 2.67 Million | 757 Thousand | -2.54 Million | 1.91 Million | 4.08 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 4.54 Million | -588 Thousand | 1.45 Million | 2.19 Million | -202 Thousand | - |
| Cash at beginning of period | 81.52 Million | 406.29 Million | 1.87 Million | 60.34 Million | 42.37 Million | 58.76 Million |
| Cash at end of period | 153.58 Million | 82.09 Million | 406.29 Million | 406.29 Million | 60.34 Million | 42.37 Million |
| Capital Expenditure | -1.46 Million | -1.61 Million | -8.99 Million | -2.97 Million | -3.9 Million | -1.49 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 72.05 Million | -324.2 Million | 404.42 Million | 345.95 Million | 17.97 Million | -16.39 Million |
| Free Cash Flow | -36.54 Million | -31.76 Million | -90.15 Million | -31.95 Million | -27.12 Million | -16.39 Million |
HXL
SESN
ATMCW
300102
PTOS
CRVO